Ilekudinol B

Overview

Ilekudinol B is an inhibitor of ACAT and PTP1B , with an IC 50 of 5.3 μM and a K i of 11.6 μM against human PTP1B. Ilekudinol B inhibits the classical pathway of the complement system , with an IC 50 of 51 μM. Ilekudinol B inhibits TNF-α-induced cellular IL-8 secretion, promotes glucose uptake in skeletal muscle myotubes, and acts as an insulin mimetic and insulin sensitizer. Ilekudinol B can be used in research related to type 2 diabetes, obesity, and inflammatory diseases.

Application

Products | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Type 2 Diabetes | Products > Disease Areas > Obesity | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Acyltransferase | Products > Signaling Pathways > Phosphatase | Products > Signaling Pathways > Interleukin Related

Product Information

• Catalog No.: HY-N17326
• CAS No.: 242794-72-5
• Molecular Formula: C29H44O4
• Molecular Weight: 456.66
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source